Technology

XPON Technologies Group (ASX:XPN) has risen 10% as the company moves through a substantial portfolio reset. June brought two divestments: Alpha Digital and the Google Marketing Platform and Google Cloud Platform business being sold to Incubeta. The transactions reduce business complexity and leave investors …

Audinate Group (ASX:AD8) has gained 7.14% as FY26 results renewed the debate around the Dante platform’s operating leverage. Revenue andGross Profitgrew, and gross margin remained around 82%, but heavier product investment pushed underlying EBITDA into a loss. The central question for FY27 is whether …

Xref (ASX:XF1) has jumped 15.25% as the company continues trying to broaden its identity beyond automated reference checking. The 2026 product strategy centres on a wider hire-to-retire platform, with xref.me adding a portable verified-profile layer alongside background checks, engagement tools and candidate data. The …

Iress (ASX:IRE) delivered one of the clearest signs yet that its multi-year simplification programme is improving profitability. First-half statutory profit rose sharply and cash EBITDA margins expanded by more than seven percentage points. Revenue growth, however, remained subdued and full-year revenue guidance was trimmed, …

Audinate Group (ASX:AD8) closed FY26 with a mixed result: revenue growth returned and gross margins stayed high, but heavier investment pushed underlyingEarningsinto the red. The owner of the Dante audio-visual networking platform is now entering FY27 with a clearer cost framework and a larger …

ReadyTech Holdings (ASX:RDY) enters its FY26 reporting period balancing two competing narratives. The enterprise software provider has secured a major public-sector education contract through the Victorian TAFE Network while also remaining subject to takeover interest from Topicus.com. At the same time, the company has …

For much of its ASX history, EchoIQ (ASX:EIQ) was valued primarily on the potential of artificial intelligence in cardiac imaging. That profile changed during 2026 after the company secured major funding, expanded relationships with healthcare technology and clinical partners, and increased usage of its …